Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET
暂无分享,去创建一个
C. Porta | J. Bellmunt | R. Bukowski | B. Escudier | D. McDermott | E. Jäger | F. Cihon | M. Moore | S. Négrier | S. Anderson | J. Lewis